内皮激活可预测接受抗CD19 CAR-T细胞治疗患者的弥散性血管内凝血、细胞因子释放综合征及预后
在38例连续纳入的侵袭性淋巴增殖性疾病患者中,于抗CD19 CAR-T输注前及输注后早期检测凝血指标。研究发现,CRS≥2级时凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、D-二聚体、因子VIII和血管性血友病因子抗原水平升高,血小板计数和抗凝血酶水平降低;基线mEASIX可预测消耗性凝血病、CRS≥2级及无进展生存期和总生存期。
要点
- CRS≥2级时凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、D-二聚体、因子VIII和血管性血友病因子抗原升高,血小板和抗凝血酶降低。
- 免疫效应细胞相关神经毒性综合征的发生与较高的凝血酶原时间、D-二聚体、因子VIII和血管性血友病因子水平及较低的纤维蛋白原和血小板计数相关。
- 较高的mEASIX评分与活化部分凝血活酶时间、纤维蛋白原、D-二聚体、因子VIII和血管性血友病因子水平升高及抗凝血酶水平降低相关。
核心结论
- 基线mEASIX可预测接受抗CD19 CAR-T细胞治疗患者的消耗性凝血病、CRS≥2级以及无进展生存期和总生存期。
研究设计与样本
- 在38例连续纳入的侵袭性淋巴增殖性疾病患者中,于基线及抗CD19 CAR-T输注后早期检测凝血实验室指标组合,并在CRS≥2级或免疫效应细胞相关神经毒性综合征时复查该组合,同时分析mEASIX、凝血生物标志物与CAR-T细胞毒性之间的关系。
主要发现
- CRS≥2级时,凝血酶原时间和活化部分凝血活酶时间延长,纤维蛋白原、D-二聚体、因子VIII和血管性血友病因子抗原水平升高,血小板计数和抗凝血酶水平降低。
- 免疫效应细胞相关神经毒性综合征的发生与较高的凝血酶原时间、D-二聚体、因子VIII和血管性血友病因子水平以及较低的纤维蛋白原水平和血小板计数相关。
- 较高的mEASIX评分与活化部分凝血活酶时间、纤维蛋白原、D-二聚体、因子VIII和血管性血友病因子水平升高及抗凝血酶水平降低相关。
- 基线mEASIX可预测消耗性凝血病、CRS≥2级、无进展生存期和总生存期。
关键数值与推荐
- mEASIX由血小板、C反应蛋白和乳酸脱氢酶组合而成。
- CRS≥2级时观察到凝血酶原时间和活化部分凝血活酶时间升高、纤维蛋白原升高、D-二聚体升高、因子VIII升高、血管性血友病因子抗原升高、血小板计数降低和抗凝血酶降低。
- 免疫效应细胞相关神经毒性综合征发生时观察到凝血酶原时间升高、D-二聚体升高、因子VIII升高、血管性血友病因子升高、纤维蛋白原降低和血小板计数降低。
- 较高的mEASIX评分与活化部分凝血活酶时间升高、纤维蛋白原升高、D-二聚体升高、因子VIII升高、血管性血友病因子升高和抗凝血酶降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cytokine release syndrome (CRS) and consumptive coagulopathy can complicate the treatment with chimeric antigen receptor T (CAR-T) cells. The modified version of the Endothelial Activation and Stress Index (mEASIX), a score derived from haematopoietic stem cell transplantation, combines platelets, C-reactive protein (CRP), and lactate dehydrogenase (LDH) and has been correlated with CRS and endothelial biomarkers. In 38 consecutive patients with aggressive lymphoproliferative disease we measured a coagulative laboratory panel at baseline and early after infusion of anti-CD19 CAR-T. The panel was investigated also in the presence of CRS graded 2 or higher, or immune effector cell-associated neurotoxicity syndrome (ICANS). Moreover, we examined the relationship between mEASIX, coagulation biomarkers, and toxicities of CAR-T cells. During CRS grade 2 or higher, we found increased prothrombin time (PT) and activated partial thromboplastin time (aPTT), fibrinogen, D-dimer, factor VIII (FVIII), and von Willebrand factor (vWF) antigen levels, and decreased platelet count and antithrombin levels. The occurrence of immune effector cell-associated neurotoxicity syndrome was associated with higher PT values, D-dimer, FVIII, and vWF levels, and decreased fibrinogen levels and platelet count. A higher mEASIX score correlated with increased aPTT values, fibrinogen, D-dimer, FVIII and vWF levels, and decreased antithrombin levels. Baseline mEASIX was predictive for consumptive coagulopathy and CRS graded 2 or higher, and for progression-free survival and overall survival.
引用
- Galli E, Sorà F, Hohaus S, et al. Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells. Br J Haematol. 2022. PMID: 36503182. doi:10.1111/bjh.18596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。